Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy and right-to-left shunt: Lack of evidence for an association in a prevalence study

European Neurology

Volumn 61, Issue 1, 2008, Pages 46-49

  Mazzucco, S ^a   Anzola, G P ^b   Ferrarini, M ^a   Taioli, F ^a   Olivato, S ^a   Burlina, A P ^c   Fabrizi, G M ^a   Rizzuto, N ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b S Orsola Hospital   (Italy)

^c San Bassiano Hospital   (Italy)

Author keywords

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; Migraine; Right to left shunt; Transcranial Doppler

Indexed keywords

ARGININE; CYSTEINE; EPIDERMAL GROWTH FACTOR; GLYCINE; NOTCH3 RECEPTOR; SERINE; TYROSINE; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CADASIL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; INTERNATIONAL HEADACHE CLASSIFICATION; MALE; MIGRAINE WITH AURA; MOLECULAR DIAGNOSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; GENETICS; HEART SEPTUM DEFECT; MIDDLE AGED; MUTATION; PREVALENCE;

ADULT; AGED; CADASIL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MUTATION; PREVALENCE; RECEPTORS, NOTCH; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 54249146461     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000165350     Document Type: Article

References (14)

1. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20. (Pubitemid 14175830)
2. Lechat P, Mas JL, Lascaut J, et al: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152.
3. Cabanes L, Mas JL, Cohen A, et al: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24: 1865-1873. (Pubitemid 23352717)
4. Handke M, Harloff A, Olschewski, Hetzel A, Geibel A: Patent foramen ovale and cryptogenetic stroke in older patients. N Engl J Med 2007; 357: 2262-2268. (Pubitemid 350190756)
5. Del Sette M, Angeli S, Leandri M, et al: Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8: 327-330.
6. Anzola GP, Magoni M, Guindani M, et al: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52: 1622-1625. (Pubitemid 29220637)
7. Markus HS, Martin RJ, Simpson MA, et al: Diagnostic strategies in CADASIL. Neurology 2002; 59: 1134-1138. (Pubitemid 35192381)
8. Singhal S, Bevan S, Barrick T, et al: The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004; 127: 2031-2038. (Pubitemid 39150261)
9. Angeli S, Carrera P, Del Sette M, et al: Very high prevalence of right-to-left shunt on transcranial Doppler in an Italian family with cerebral autosomal dominant angiopathy with subcortical infarcts and leukoencephalopathy. Eur Neurol 2001; 46: 198-201. (Pubitemid 33135793)
10. ClinicalTrials.gov: http://www.clinicaltrials. gov (accessed April 11, 2008).
11. Dowson A, Mullen MJ, Peatfield R, et al: Migraine Intervention With STARFlex Technology (MIST) Trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117: 1397-1404. (Pubitemid 351501492)
12. Jauss M, Zanette E: Detection of right to left shunt with ultrasound contrast agent and Transcranial Doppler sonography. Cerebrovasc Dis 2000; 10: 490-496.
13. Headache Classification Subcommittee of the International Headache Society: International headache classification. Cephalalgia 2004; 24(suppl 1):8-160.
14. Vérin M, Rolland Y, Landgraf F, et al: New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry 1995; 59: 579-585.